Conjugated docosahexaenoic acid inhibits lipid accumulation in rats

Journal of Nutritional Biochemistry

Volumn 17, Issue 8, 2006, Pages 518-524

  Tsuzuki, Tsuyoshi ^a   Kawakami, Yuki ^b   Nakagawa, Kiyotaka ^b   Miyazawa, Teruo ^b  

^a MIYAGI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Antiobesity; Conjugated docosahexaenoic acid; Conjugated fatty acid; Conjugated linoleic acid

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUCOSE; LINOLEIC ACID; LIPID; SUGAR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; ISOMERIZATION; LIPID METABOLISM; LIPID STORAGE; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIET; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; HYDROGEN-ION CONCENTRATION; INSULIN; ISOMERISM; LEPTIN; LINOLEIC ACID; LINOLEIC ACIDS, CONJUGATED; LIPID METABOLISM; LIVER; MALE; ORGAN SIZE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; SAFFLOWER OIL; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

ANIMALIA;

EID: 33746022297     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2005.09.006     Document Type: Article

References (42)

1. Sharadi Y., and Eldad A. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity. Am J Med 109 (2000) 171
2. Park Y., Albright K.J., Storkson J.M., Liu W., Cook M.E., and Pariza M.W. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 34 (1999) 243-248
3. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., Kim H.J., Tange T., Okuyama H., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49 (2000) 1534-1542
4. Berven G., Bye A., Hals O., Blankson H., Fagertun H., Thom E., et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci 102 (2002) 455-462
5. Kreider R.B., Ferreira M.P., Greenwood M., Wilson M., and Almada A.L. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res 16 (2002) 325-334
6. Ha Y.L., Grimm N.K., and Pariza M.W. Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 8 (1987) 1881-1887
7. Ip C., Chin S.F., Scimeca J.A., and Pariza M.W. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 51 (1991) 6118-6124
8. Ip C., Singh M., Thompson H.J., and Scimeca J.A. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rats. Cancer Res 54 (1991) 1212-1215
9. Lee K.N., Kritchevsky D., and Pariza M.W. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108 (1994) 19-25
10. Badami R.C., and Patil K.B. Structure and occurrence of unusual fatty acids in minor seed oils. Prog Lipid Res 19 (1981) 119-153
11. Lopez A., and Gerwick W.H. Two new eicosapentaenoic acids from the temperate red seaweed Ptilota filicina. J Agardh Lipids 22 (1987) 190-194
12. Mikhailova M.V., Bemis D.L., Wise M.L., Gerwick W.H., Norris J.N., and Jacobs R.S. Structure and biosynthesis of novel conjugated polyene fatty acids from the marine green alga Anadyomene stellate. Lipids 30 (1995) 583-589
13. Tsuzuki T., Igarashi M., Komai M., and Miyazawa T. A metabolic conversion of 9, 11, 13-eleostearic acid (18:3) to 9, 11-conjugated linoleic acid (18:2) in the rat. J Nutr Sci Vitaminol 49 (2003) 195-200
14. Igarashi M., Tsuzuki T., Kambe T., and Miyazawa T. Recommended methods of fatty acid methylester preparation for conjugated dienes and trienes in food and biological samples. J Nutr Sci Vitaminol 50 (2004) 121-128
15. Tsuzuki T., Tokuyama Y., Igarashi M., and Miyazawa T. Tumor growth suppression by α-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 25 (2004) 1417-1425
16. Tsuzuki T., Igarashi M., and Miyazawa T. Conjugated eicosapentaenoic acid inhibits transplanted tumor growth via membrane lipid peroxidation in nude mice. J Nutr 134 (2004) 1162-1166
17. Tsuzuki T., Igarashi M., Iwata T., Yamauchi-Sato Y., Yamamoto T., Ogita K., et al. Oxidation rate of conjugated linoleic acid and conjugated linolenic acid is slowed by triacylglycerol esterification and α-tocopherol. Lipids 39 (2004) 475-480
18. Tsuzuki T., Tokuyama Y., Igarashi M., Nakagawa K., Ohsaki Y., Komai M., et al. α-Eleostearic acid (9Z11E13E-18:3) is quickly converted to conjugated linoleic acid (9Z11E-18:2) in rats. J Nutr 134 (2004) 2634-2639
19. Tsuzuki T., Tanaka K., Kuwahara S., and Miyazawa T. Synthesis of the conjugated trienes 5E,7E,9E,14Z,17Z-eicosapentaenoic acid and 5Z,7E,9E,14Z,17Z-eicosapentaenoic acid, and their induction of apoptosis in DLD-1 colorectal adenocarcinoma human cells. Lipids 40 (2005) 147-154
20. yMice fed with eicosapentaenoic and docosahexaenoic acids in addition to linolenic acid. Biochem Biophys Res Commun 259 (1999) 85-90
21. In: Helrich K. (Ed). Acids (polyunsaturated) in oil and fats. Official methods of analysis of the Association of Official Analytical Chemists (1990), Association of Official Analytical Chemists, Arlington 960-963
22. Pitt G.A.J., and Morton R.A. Ultra-violet spectrophotometry of fatty acids. Prog Chem Fats Other Lipids 4 (1957) 227-278
23. Folch J., Lees M., and Stanley Sloane G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 497-509
24. Bartlett G.R. Colorimetric assay methods for free and phosphorylated glyceric acids. J Biol Chem 226 (1957) 497-509
25. Nepokroeff C.M., Lakshmanan M.R., and Porter J.W. Fatty acid synthase from rat liver. Methods Enzymol 37 (1975) 37-44
26. Ochoa S., Mehler A.H., and Kornberg A. Biosynthesis of dicarboxylic acids by carbon dioxide fixation: I. Isolation and properties of an enzyme from pigeon liver catalyzing the reversible oxidative decarboxylation of I-malic acid. J Biol Chem 174 (1948) 977-1000
27. Small G.M., Burdett K., and Connock M.J. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227 (1985) 205-210
28. Osmundsen H., Bremer J., and Pedersen J.I. Metabolic aspects of peroxisomal β-oxidation. Biochim Biophys Acta 1085 (1991) 141-158
29. Schoonjans K., Staels B., and Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37 (1996) 907-925
30. Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A 94 (1997) 4312-4317
31. Lehmann J., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kiewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270 (1995) 12953-12956
32. Murakami K., Tobe K., Ide T., Mochizuki T., Ohashi M., Akanuma Y., et al. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-α (PPAR-α) and PPAR-γ. Diabetes 47 (1998) 1841-1847
33. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptor α and γ. Proc Natl Acad Sci U S A 94 (1997) 4318-4323
34. Moya-Camarena S.Y., Heuvel J.P.V., Blanchard S.G., Leesnitzer L.A., and Belury M.A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR alpha. J Lipid Res 40 (1999) 1426-1433
35. Belury M.A., and Vanden Heuvel J.P. Modulation of diabetes by conjugated linoleic acid. Advance in conjugated linoleic acid research 1 (1999), AOCS Press, Champaign 404-411
36. Evans M., Park Y., Pariza M., Curtis L., Kuebler B., and McIntosh M. Trans-10, cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor gamma2 and aP2 expression in 3T3-L1 preadipocytes. Lipids 36 (2001) 1223-1232
37. Peters J.M., Park Y., Gonzalez F.J., and Pariza M.W. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice. Biochim Biophys Acta 1533 (2001) 233-242
38. Houseknecht K.L., Vanden Heuvel J.P., Moya-Camarena S.Y., Portocarrero C.P., Peck L.W., Nickel K.P., et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244 (1998) 678-682
39. Ryder J.W., Portocarrero C.P., Song X.M., Cui L., Yu M., Combatsiari T., et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 50 (2001) 1149-1157
40. Stangl G.I., Muller H., and Kirchgessner M. Conjugated linoleic acid effects on circulating hormones, metabolites and lipoproteins, and its proportion in fasting serum and erythrocyte membrane of swine. Eur J Nutr 38 (1999) 271-277
41. Medina E.A., Horn W.F., Keim N.L., Havel P.J., Benito P., Kelley G.J., et al. Conjugated linoleic acid supplementation in human: effect on circulating leptin concentrations and appetite. Lipids 35 (2000) 783-788
42. Tsigos C., Kyrou I., Chala E., Tsapagas P., Stavridis J.C., and Raptis S.A. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48 (1999) 1332-1335